IBB vs VFH
iShares Biotechnology ETF vs Vanguard Financials ETF
- • VFH has the lower expense ratio at 0.09% vs 0.44% for IBB.
- • VFH pays a higher dividend yield (1.71%).
Side-by-side metrics
| Metric | IBB | VFH |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.09% |
Dividend yield Trailing 12-month yield. | 0.16% | 1.71% |
AUM Assets under management — bigger funds are typically more liquid. | $11.50B | $14.54B |
YTD return | 30.22% | 6.78% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.60 | 0.76 |
P/E ratio | 25.48 | 15.99 |
Last price | $217.75 | $141.53 |
Inception | — | — |
Issuer | iShares | Vanguard |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
VFH top holdings
| JPM | JPMorgan Chase & Co | 10.42% |
| BRK-B | Berkshire Hathaway Inc Class B | 8.32% |
| V | Visa Inc Class A | 7.07% |
| MA | Mastercard Inc Class A | 5.30% |
| BAC | Bank of America Corp | 4.19% |
| GS | The Goldman Sachs Group Inc | 2.94% |
| WFC | Wells Fargo & Co | 2.87% |
| MS | Morgan Stanley | 2.63% |
| C | Citigroup Inc | 2.60% |
| SCHW | Charles Schwab Corp | 1.91% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About VFH
VFH (Vanguard Financials ETF) is US financial services sector stocks. Managed by Vanguard, the fund carries $14.5B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.71%. Its largest holding is JPMorgan Chase & Co (JPM), which represents 10.4% of the portfolio. Real Estate is the fund's largest sector exposure at 0.6%.